Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders

Anaerobe

Volumn 49, Issue , 2018, Pages 121-131

  Kang, Dae Wook ^a   Ilhan, Zehra Esra ^a   Isern, Nancy G ^b   Hoyt, David W ^b   Howsmon, Daniel P ^c,d   Shaffer, Michael ^e,f   Lozupone, Catherine A ^e   Hahn, Juergen ^c,d   Adams, James B ^g   Krajmalnik Brown, Rosa ^a,g  

^a ARIZONA STATE UNIVERSITY   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^d RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g Arizona State University   (United States)

Author keywords

Autism; Autism biomarkers; Fecal metabolites; Gut bacteria; Gut microbiome; Metabolomics

Indexed keywords

2 PROPANOL; 4 AMINOBUTYRIC ACID; ASPARTIC ACID; DECANOIC ACID; GENOMIC DNA; GLUTAMINE; NICOTINIC ACID; PARA CRESOL; RNA 16S; THYMINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BIOLOGICAL MARKER;

16S RRNA GENE; ADOLESCENT; AMPLICON; ARTICLE; AUTISM; BACTERIUM; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEACALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FECES LEVEL; FECES MICROFLORA; FEMALE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; MALE; METABOLITE; MICROBIAL DIVERSITY; NONHUMAN; POPULATION ABUNDANCE; PREVOTELLA; PREVOTELLA COPRI; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RNA SEQUENCE; SPECIES COMPOSITION; BIODIVERSITY; CHEMISTRY; CLASSIFICATION; FECES; GENETICS; INTESTINE FLORA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PRESCHOOL CHILD;

2-PROPANOL; ADOLESCENT; AUTISM SPECTRUM DISORDER; BACTERIA; BIODIVERSITY; BIOMARKERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; NEUROTRANSMITTER AGENTS;

EID: 85040318286     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2017.12.007     Document Type: Article

References (87)

1. Lai, M.C., Lombardo, M.V., Baron-Cohen, S., Autism. Lancet 383 (2014), 896–910.
2. CDC, Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. 2014, 1–21 MMWR Surveill Summ. United States.
3. Sharon, G., Sampson, T.R., Geschwind, D.H., Mazmanian, S.K., The central nervous system and the gut microbiome. Cell 167 (2016), 915–932.
4. Kim, S., Kim, H., Yim, Y.S., Ha, S., Atarashi, K., Tan, T.G., et al. Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature 549 (2017), 528–532.
5. Buie, T., Campbell, D.B., Fuchs, G.J., Furuta, G.T., Levy, J., Van de Water, J., et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in Individuals with ASDs: a consensus report. Pediatrics 125 (2010), S1–S18.
6. McElhanon, B.O., McCracken, C., Karpen, S., Sharp, W.G., Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics 133 (2014), 872–883.
7. Kang, D.W., Park, J.G., Ilhan, Z.E., Wallstrom, G., Labaer, J., Adams, J.B., et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One, 8, 2013, e68322.
8. Williams, B.L., Hornig, M., Buie, T., Bauman, M.L., Paik, M.C., Wick, I., et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLos One, 6, 2011, e24585.
9. Tomova, A., Husarova, V., Lakatosova, S., Bakos, J., Vlkova, B., Babinska, K., et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiol. Behav. 138 (2015), 179–187.
10. Finegold, S.M., Dowd, S.E., Gontcharova, V., Liu, C., Henley, K.E., Wolcott, R.D., et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe, 16, 2010.
11. Song, Y.L., Liu, C.X., Finegold, S.A., Real-time PCR quantitation of Clostridia in feces of autistic children. Appl. Environ. Microbiol. 70 (2004), 6459–6465.
12. Parracho, H., Bingham, M.O., Gibson, G.R., McCartney, A.L., Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 54 (2005), 987–991.
13. Finegold, S.M., Molitoris, D., Song, Y.L., Liu, C.X., Vaisanen, M.L., Bolte, E., et al. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35 (2002), S6–S16.
14. De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D.I., et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLos One, 8, 2013, 18.
15. Wang, L., Christophersen, C.T., Sorich, M.J., Gerber, J.P., Angley, M.T., Conlon, M.A., Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl. Environ. Microbiol. 77 (2011), 6718–6721.
16. Adams, J.B., Johansen, L.J., Powell, L.D., Quig, D., Rubin, R.A., Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol., 11, 2011, 22.
17. Williams, B.L., Hornig, M., Parekh, T., Lipkin, W.I., Application of novel PCR-based methods for detection, quantification, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. mBio, 3, 2012, e00261-11.
18. Son, J.S., Zheng, L.J., Rowehl, L.M., Tian, X.Y., Zhang, Y.H., Zhu, W., et al. Comparison of fecal microbiota in children with autism spectrum disorders and neurotypical siblings in the Simons simplex sollection. PLos One, 10, 2015, 19.
19. Gondalia, S.V., Palombo, E.A., Knowles, S.R., Cox, S.B., Meyer, D., Austin, D.W., Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res. 5 (2012), 419–427.
20. Krajmalnik-Brown, R., Lozupone, C., Kang, D.W., Adams, J.B., Gut bacteria in children with autism spectrum disorders: challenges and promise of studying how a complex community influences a complex disease. Microb. Ecol. Health Dis., 26, 2015.
21. Huttenhower, C., Gevers, D., Knight, R., Abubucker, S., Badger, J.H., Chinwalla, A.T., et al. Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
22. Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopment disorders. Cell 155 (2013), 1451–1463.
23. MacFabe, D.F., Cain, N.E., Boon, F., Ossenkopp, K.-P., Cain, D.P., Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav. Brain Res. 217 (2011), 47–54.
24. Buffington, S.A., Di Prisco, G.V., Auchtung, T.A., Ajami, N.J., Petrosino, J.F., Costa-Mattioli, M., Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165 (2016), 1762–1775.
25. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 16050–16055.
26. Foley, K.A., Ossenkopp, K.P., Kavaliers, M., MacFabe, D.F., Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner. PLos One, 9, 2014.
27. Donaldson, Z.R., Young, L.J., Oxytocin, vasopressin, and the neurogenetics of sociality. Science 322 (2008), 900–904.
28. Young, L.J., Barrett, C.E., Can oxytocin treat autism?. Science 347 (2015), 825–826.
29. Ooi, Y.P., Weng, S.J., Kossowsky, J., Gerger, H., Sung, M., Oxytocin, spectrum, autism, disorders: a systematic review and meta-analysis of randomized controlled trials. Pharmacopsychiatry, 50, 2017, 9.
30. Adams, J.B., Audhya, T., McDonough-Means, S., Rubin, R.A., Quig, D., Geis, E., et al. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr., 11, 2011.
31. Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K.J., et al. Increased serum levels of glutamate in adult patients with autism. Prog. Neuro Psychopharmacol. Biol. Psychiatr. 30 (2006), 1472–1477.
32. Ming, X., Stein, T.T.P., Barnes, V., Rhodes, N., Guo, L.N., Metabolic perturbance in autism spectrum disorders: a metabolomics study. J. Proteome Res. 11 (2012), 5856–5862.
33. Yap, I.K.S., Angley, M., Veselkov, K.A., Holmes, E., Lindon, J.C., Nicholson, J.K., Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J. Proteome Res. 9 (2010), 2996–3004.
34. Gabriele, S., Sacco, R., Cerullo, S., Neri, C., Urbani, A., Tripi, G., et al. Urinary p-cresol is elevated in young French children with autism spectrum disorder: a replication study. Biomarkers 19 (2014), 463–470.
35. Gevi, F., Zolla, L., Gabriele, S., Persico, A.M., Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Mol. Autism., 7, 2016, 11.
36. Wang, L., Christophersen, C.T., Sorich, M.J., Gerber, J.P., Angley, M.T., Conlon, M.A., Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig. Dis. Sci. 57 (2012), 2096–2102.
37. Wolcott, R.D., Gontcharova, V., Sun, Y., Dowd, S.E., Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and Titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol., 9, 2009.
38. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods, 7, 2010.
39. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26 (2010), 2460–2461.
40. Haas, B.J., Gevers, D., Earl, A.M., Feldgarden, M., Ward, D.V., Giannoukos, G., et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21 (2011), 494–504.
41. Cole, J.R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R.J., et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 37 (2009), D141–D145.
42. Faith, D.P., Conservation evaluation and phylogenetic diversity. Biol. Conserv. 61 (1992), 1–10.
43. Lozupone, C., Knight, R., UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71 (2005), 8228–8235.
44. Langille, M.G.I., Zaneveld, J., Caporaso, J.G., McDonald, D., Knights, D., Reyes, J.A., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol., 31, 2013 814-+.
45. Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., Morishima, K., KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45 (2017), D353–D361.
46. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. B 57 (1995), 289–300.
47. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13 (2003), 2498–2504.
48. Slaughter, R.J., Mason, R.W., Beasley, D.M.G., Vale, J.A., Schep, L.J., Isopropanol poisoning. Clin. Toxicol. 52 (2014), 470–478.
49. Brown, T.L., Gamon, S., Tester, P., Martin, R., Hosking, K., Bowkett, G.C., et al. Can alcohol-based hand-rub solutions cause you to lose your driver's license? Comparative cutaneous absorption of various alcohols. Antimicrob. Agents Chemother. 51 (2007), 1107–1108.
50. Krautt, J.A., Kurtztt, I., Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin. J. Am. Soc. Nephrol. 3 (2008), 208–225.
51. Abramson, S., Singh, A.K., Treatment of the alcohol intoxications: ethylene glycol, methanol and isopropanol. Curr. Opin. Nephrol. Hypertens. 9 (2000), 695–701.
52. Jones, D.T., Woods, D.R., Acetone-butanol fermentation revisited. Microbiol. Rev. 50 (1986), 484–524.
53. Hoshino, K., Udagawa, K., Organism producing isopropanol from acetone. VI. Isopropanol dehydrogenase and alcohol dehydrogenase of Lactobacillus brevis var. hofuensis. [in Japanese] Nippon. Nogei Kagaku Kaishi 34 (1960), 616–619.
54. Chen, J.S., Alcohol-dehydrogenase - multiplicity and relatedness in the solvent-producing clostridia. FEMS Microbiol. Rev. 17 (1995), 263–273.
55. George, H.A., Johnson, J.L., Moore, W.E.C., Holdeman, L.V., Chen, J.S., Acetone, isopropanol, and butanol production by Clostridium-Beijerinckii (syn Clostridium-butylicum) and Clostridium-Aurantibutyricum. Appl. Environ. Microbiol. 45 (1983), 1160–1163.
56. Chen, J.S., Hiu, S.F., Acetone butanol isopropanol production by Clostridium-Beijerinckii (synonym, Clostridium-Butylicum). Biotechnol. Lett. 8 (1986), 371–376.
57. Persico, A.M., Napolioni, V., Urinary p-cresol in autism spectrum disorder. Neurotoxicol. Teratol. 36 (2013), 82–90.
58. Selmer, T., Andrei, P.I., p-Hydroxyphenylacetate decarboxylase from Clostridium difficile - a novel glycyl radical enzyme catalysing the formation of p-cresol. Eur. J. Biochem. 268 (2001), 1363–1372.
59. Chen, B.X., Morioka, S., Nakagawa, T., Hayakawa, T., Resistant starch reduces colonic and urinary p-cresol in rats fed a tyrosine-supplemented diet, whereas konjac mannan does not. Biosci. Biotechnol. Biochem. 80 (2016), 1995–2000.
60. Dou, L., Bertrand, E., Cerini, C., Faure, V., Sampol, J., Vanholder, R., et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int. 65 (2004), 442–451.
61. Shiba, T., Kawakami, K., Sasaki, T., Makino, I., Kato, I., Kobayashi, T., et al. Effects of intestinal bacteria-derived p-cresyl sulfate on Th1-type immune response in vivo and in vitro. Toxicol. Appl. Pharmacol. 274 (2014), 191–199.
62. Cheng, Y., Xie, G.X., Chen, T.L., Qiu, Y.P., Zou, X., Zheng, M.H., et al. Distinct urinary metabolic profile of human colorectal cancer. J. Proteome Res. 11 (2012), 1354–1363.
63. Andriamihaja, M., Lan, A., Beaumont, M., Audebert, M., Wong, X., Yamada, K., et al. The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells. Free Radic. Biol. Med. 85 (2015), 219–227.
64. Thomas, R.H., Meeking, M.M., Mepham, J.R., Tichenoff, L., Possmayer, F., Liu, S.Y., et al. The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J. Neuroinflammation, 9, 2012, 18.
65. Peng, L.Y., Li, Z.R., Green, R.S., Holzman, I.R., Lin, J., Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 139 (2009), 1619–1625.
66. Canani, R.B., Di Costanzo, M., Leone, L., Pedata, M., Meli, R., Calignano, A., Potential beneficial effects of butyrate in intestinal and extrainitestinal diseases. World J. Gastroenterol. 17 (2011), 1519–1528.
67. Flashner, B.M., Russo, M.E., Boileau, J.E., Leong, D.W., Gallicano, G.I., Epigenetic factors and autism spectrum disorders. NeuroMolecular Med. 15 (2013), 339–350.
68. El-Ansary, A., Al-Ayadhi, L., GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders. J. Neuroinflammation, 11, 2014.
69. Wu, Q.L., Law, Y.S., Shah, N.P., Dairy Streptococcus thermophilus improves cell viability of Lactobacillus brevis NPS-QW-145 and its gamma-aminobutyric acid biosynthesis ability in milk. Sci. Rep., 5, 2015, 12.
70. Sills, M.A., Forsythe, W.I., Haidukewych, D., Role of octanoic and decanoic acids in the control of seizures. Arch. Dis. Child. 61 (1986), 1173–1177.
71. Chang, P., Augustin, K., Boddum, K., Williams, S., Sun, M., Terschak, J.A., et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain 139 (2016), 431–443.
72. Stone, T.W., Burton, N.R., NMDA receptors and ligands in the vertebrate CNS. Prog. Neurobiol. 30 (1988), 333–368.
73. Lee, E.J., Choi, S.Y., Kim, E., NMDA receptor dysfunction in autism spectrum disorders. Curr. Opin. Pharmacol. 20 (2015), 8–13.
74. Albrecht, J., Sidoryk-Wegrzynowicz, M., Zielinska, M., Aschner, M., Roles of glutamine in neurotransmission. Neuron Glia Biol. 6 (2010), 263–276.
75. Kim, D.Y., Camilleri, M., Serotonin: a mediator of the brain-gut connection. Am. J. Gastroenterol. 95 (2000), 2698–2709.
76. Kang, D.-W., Adams, J.B., Gregory, A.C., Borody, T., Chittick, L., Fasano, A., et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome, 5, 2017, 10.
77. Son, J.S., Zheng, L.J., Rowehl, L.M., Tian, X.Y., Zhang, Y.H., Zhu, W., et al. Comparison of fecal microbiota in children with autism spectrum disorders and neurotypical siblings in the Simons simplex sollection. PLos One, 10, 2015.
78. Lim, J.S., Lim, M.Y., Choi, Y., Ko, G., Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia. Mol. Brain, 10, 2017, 14.
79. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 16731–16736.
80. Quevrain, E., Maubert, M.A., Michon, C., Chain, F., Marquant, R., Tailhades, J., et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 65 (2016), 415–425.
81. Rajilic-Stojanovic, M., Biagi, E., Heilig, H., Kajander, K., Kekkonen, R.A., Tims, S., et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141 (2011), 1792–1801.
82. Deufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., et al. Abnormal intestinal permeability in children with autism. Acta Paedol. 85 (1996), 1076–1079.
83. de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr. 51 (2010), 418–424.
84. Kosikowska, U., Biernasiuk, A., Rybojad, P., Los, R., Malm, A., Haemophilus parainfluenzae as a marker of the upper respiratory tract microbiota changes under the influence of preoperative prophylaxis with or without postoperative treatment in patients with lung cancer. BMC Microbiol., 16, 2016, 9.
85. Mitchell, J.L., Hill, S.L., Immune response to Haemophilus parainfluenzae in patients with chronic obstructive lung disease. Clin. Diagn. Lab. Immunol. 7 (2000), 25–30.
86. Backhed, F., Roswall, J., Peng, Y.Q., Feng, Q., Jia, H.J., Kovatcheva-Datchary, P., et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17 (2015), 690–703.
87. Saulnier, D.M., Riehle, K., Mistretta, T.A., Diaz, M.A., Mandal, D., Raza, S., et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141 (2011), 1782–1791.